Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7530 | 1358 | 42.5 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
501 | 3 | SYSTEMIC SCLEROSIS//SCLERODERMA//IDIOPATHIC PULMONARY FIBROSIS | 22108 |
968 | 2 | IDIOPATHIC PULMONARY FIBROSIS//INTERSTITIAL LUNG DISEASE//PULMONARY FIBROSIS | 10678 |
7530 | 1 | BLEOMYCIN//PULMONARY FIBROSIS//LUNG FIBROSIS | 1358 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BLEOMYCIN | authKW | 796881 | 17% | 15% | 237 |
2 | PULMONARY FIBROSIS | authKW | 592754 | 16% | 12% | 214 |
3 | LUNG FIBROSIS | authKW | 190677 | 5% | 13% | 67 |
4 | LUNG CELLULAR MOL BIOL | address | 126644 | 1% | 43% | 13 |
5 | MALLORY PATHOL | address | 73566 | 1% | 27% | 12 |
6 | FEITAI | authKW | 67452 | 0% | 100% | 3 |
7 | LUNG BIOL PROGRAM | address | 67428 | 1% | 20% | 15 |
8 | IDIOPATHIC PULMONARY FIBROSIS | authKW | 61721 | 4% | 5% | 60 |
9 | BLEOMYCIN INDUCED LUNG INJURY | authKW | 51388 | 0% | 57% | 4 |
10 | MED SL9 | address | 50587 | 0% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 26958 | 37% | 0% | 498 |
2 | Pathology | 2277 | 12% | 0% | 164 |
3 | Critical Care Medicine | 2259 | 8% | 0% | 112 |
4 | Cell Biology | 876 | 15% | 0% | 199 |
5 | Toxicology | 768 | 8% | 0% | 106 |
6 | Medicine, Research & Experimental | 602 | 9% | 0% | 121 |
7 | Pharmacology & Pharmacy | 482 | 13% | 0% | 181 |
8 | Physiology | 442 | 7% | 0% | 97 |
9 | Immunology | 308 | 9% | 0% | 122 |
10 | Biochemistry & Molecular Biology | 212 | 15% | 0% | 201 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUNG CELLULAR MOL BIOL | 126644 | 1% | 43% | 13 |
2 | MALLORY PATHOL | 73566 | 1% | 27% | 12 |
3 | LUNG BIOL PROGRAM | 67428 | 1% | 20% | 15 |
4 | MED SL9 | 50587 | 0% | 75% | 3 |
5 | 27005 76TH AVE | 22484 | 0% | 100% | 1 |
6 | AFFILIATED HOSP 1 E PHARMACEUT CHEM 3 | 22484 | 0% | 100% | 1 |
7 | AFFILIATED JIANGBIN HOSP | 22484 | 0% | 100% | 1 |
8 | AFFILIATED JIANGSU PROVINCE HOSP TRADIT CHINESE M | 22484 | 0% | 100% | 1 |
9 | AMT INTERNAL MED | 22484 | 0% | 100% | 1 |
10 | ANALISI CLIN MICROBIOL | 22484 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERIMENTAL LUNG RESEARCH | 38494 | 4% | 3% | 55 |
2 | AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY | 21726 | 5% | 1% | 70 |
3 | AMERICAN REVIEW OF RESPIRATORY DISEASE | 21581 | 6% | 1% | 77 |
4 | AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | 13651 | 4% | 1% | 59 |
5 | AMERICAN JOURNAL OF PATHOLOGY | 5319 | 4% | 0% | 55 |
6 | RESPIRATORY RESEARCH | 4052 | 1% | 1% | 18 |
7 | CHEST | 3647 | 4% | 0% | 59 |
8 | AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 3484 | 3% | 0% | 39 |
9 | LUNG | 2948 | 1% | 1% | 16 |
10 | EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2705 | 1% | 1% | 18 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BLEOMYCIN | 796881 | 17% | 15% | 237 | Search BLEOMYCIN | Search BLEOMYCIN |
2 | PULMONARY FIBROSIS | 592754 | 16% | 12% | 214 | Search PULMONARY+FIBROSIS | Search PULMONARY+FIBROSIS |
3 | LUNG FIBROSIS | 190677 | 5% | 13% | 67 | Search LUNG+FIBROSIS | Search LUNG+FIBROSIS |
4 | FEITAI | 67452 | 0% | 100% | 3 | Search FEITAI | Search FEITAI |
5 | IDIOPATHIC PULMONARY FIBROSIS | 61721 | 4% | 5% | 60 | Search IDIOPATHIC+PULMONARY+FIBROSIS | Search IDIOPATHIC+PULMONARY+FIBROSIS |
6 | BLEOMYCIN INDUCED LUNG INJURY | 51388 | 0% | 57% | 4 | Search BLEOMYCIN+INDUCED+LUNG+INJURY | Search BLEOMYCIN+INDUCED+LUNG+INJURY |
7 | BLEOMYCINE | 44968 | 0% | 100% | 2 | Search BLEOMYCINE | Search BLEOMYCINE |
8 | BRONCHOALVEOLAR STEM CELL | 29977 | 0% | 67% | 2 | Search BRONCHOALVEOLAR+STEM+CELL | Search BRONCHOALVEOLAR+STEM+CELL |
9 | PEPLOMYCIN | 26971 | 0% | 20% | 6 | Search PEPLOMYCIN | Search PEPLOMYCIN |
10 | 4 OXOQUINOLINE 3 CARBOXAMIDES | 22484 | 0% | 100% | 1 | Search 4+OXOQUINOLINE+3+CARBOXAMIDES | Search 4+OXOQUINOLINE+3+CARBOXAMIDES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MOELLER, A , ASK, K , WARBURTON, D , GAULDIE, J , KOLB, M , (2008) THE BLEOMYCIN ANIMAL MODEL: A USEFUL TOOL TO INVESTIGATE TREATMENT OPTIONS FOR IDIOPATHIC PULMONARY FIBROSIS?.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 40. ISSUE 3. P. 362 -382 | 106 | 51% | 264 |
2 | WILLIAMSON, JD , SADOFSKY, LR , HART, SP , (2015) THE PATHOGENESIS OF BLEOMYCIN-INDUCED LUNG INJURY IN ANIMALS AND ITS APPLICABILITY TO HUMAN IDIOPATHIC PULMONARY FIBROSIS.EXPERIMENTAL LUNG RESEARCH. VOL. 41. ISSUE 2. P. 57 -73 | 54 | 32% | 9 |
3 | GERARDUZZI, C , HE, QW , ZHAI, BB , ANTONIOU, J , DI BATTISTA, JA , (2017) PROSTAGLANDIN E2-DEPENDENT PHOSPHORYLATION OF RAS INHIBITION 1 (RIN1) AT SER 291 AND 292 INHIBITS TRANSFORMING GROWTH FACTOR-BETA-INDUCED RAS ACTIVATION PATHWAY IN HUMAN SYNOVIAL FIBROBLASTS: ROLE IN CELL MIGRATION.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 232. ISSUE 1. P. 202 -215 | 27 | 38% | 1 |
4 | MOORE, BB , HOGABOAM, CM , (2008) MURINE MODELS OF PULMONARY FIBROSIS.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. VOL. 294. ISSUE 2. P. L152-L160 | 31 | 41% | 287 |
5 | TOBWALA, S , FAN, W , STOEGER, T , ERCAL, N , (2013) N-ACETYLCYSTEINE AMIDE, A THIOL ANTIOXIDANT, PREVENTS BLEOMYCIN-INDUCED TOXICITY IN HUMAN ALVEOLAR BASAL EPITHELIAL CELLS (A549).FREE RADICAL RESEARCH. VOL. 47. ISSUE 9. P. 740-749 | 33 | 47% | 9 |
6 | BOZYK, PD , MOORE, BB , (2011) PROSTAGLANDIN E-2 AND THE PATHOGENESIS OF PULMONARY FIBROSIS.AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. VOL. 45. ISSUE 3. P. 445-452 | 37 | 40% | 41 |
7 | GHARAEE-KERMANI, M , PHAN, SH , (2005) MOLECULAR MECHANISMS OF AND POSSIBLE TREATMENT STRATEGIES FOR IDIOPATHIC PULMONARY FIBROSIS.CURRENT PHARMACEUTICAL DESIGN. VOL. 11. ISSUE 30. P. 3943-3971 | 60 | 30% | 46 |
8 | VERMA, R , BRAHMANKAR, M , KUSHWAH, L , SURESH, B , (2013) EVALUATING THE INHIBITORY POTENTIAL OF SULINDAC AGAINST THE BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN WISTAR RATS.ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY. VOL. 36. ISSUE 3. P. 769-778 | 24 | 65% | 4 |
9 | CHANDLER, DB , (1990) POSSIBLE MECHANISMS OF BLEOMYCIN-INDUCED FIBROSIS.CLINICS IN CHEST MEDICINE. VOL. 11. ISSUE 1. P. 21-30 | 39 | 76% | 71 |
10 | FAILLA, M , GENOVESE, T , MAZZON, E , FRUCIANO, M , FAGONE, E , GILI, E , BARERA, A , LA ROSA, C , CONTE, E , CRIMI, N , ET AL (2009) 16,16-DIMETHYL PROSTAGLANDIN E-2 EFFICACY ON PREVENTION AND PROTECTION FROM BLEOMYCIN-INDUCED LUNG INJURY AND FIBROSIS.AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. VOL. 41. ISSUE 1. P. 50 -58 | 25 | 66% | 16 |
Classes with closest relation at Level 1 |